In this study, we analyzed several common polymorphisms of FGFR4 in 346 Chinese men with clinically localized prostate cancer and investigated the prognostic role of these genetic variants in biochemical recurrence (BCR) after radical prostatectomy. This evidence concerns the gene FGFR4 and Familial prostate cancer.